Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy
- 1 September 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (14) , F117-F121
- https://doi.org/10.1097/00002030-200009290-00001
Abstract
To analyse the virological and clinical efficacy of cidofovir combined with highly active antiretroviral therapy (HAART) in AIDS-related progressive multifocal leukoencephalopathy (PML).Keywords
This publication has 12 references indexed in Scilit:
- Natural history of HIV infection in the_era of combination antiretroviral therapyAIDS, 1999
- Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitorsAIDS, 1999
- Progressive Multifocal Leukoencephalopathy: Improved Survival of Human Immunodeficiency Virus–infected Patients in the Protease Inhibitor EraThe Journal of Infectious Diseases, 1999
- Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapyZeitschrift für Neurologie, 1999
- Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patientsAIDS, 1999
- Monitoring the Response of AIDS-Related Progressive Multifocal Leukoencephalopathy to HAART and Cidofovir by PCR for JC Virus DNA in the CSFEuropean Neurology, 1999
- Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathyNeurology, 1999
- Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS‐Associated Progressive Multifocal LeukoencephalopathyClinical Infectious Diseases, 1999
- Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapyAIDS, 1998
- Successful Resolution of Progressive Multifocal Leukoencephalopathy After Combination Therapy with Cidofovir and Cytosine ArabinosideClinical Infectious Diseases, 1998